Diabetes mellitus and tuberculosis: Pattern of tuberculosis, two-month smear conversion and treatment outcomes in Guangzhou, China

Tropical Medicine and International Health

Volumn 18, Issue 11, 2013, Pages 1379-1385

  Mi, Fengling ^a   Tan, Shouyong ^b,c   Liang, Li ^a   Harries, Anthony D ^d,e   Hinderaker, Sven G ^f   Lin, Yan ^g   Yue, Wentao ^a   Chen, Xi ^a   Liang, Bing ^b,c   Gong, Fang ^b,c   Du, Jian ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b GUANGZHOU CHEST HOSPITAL   (China)

^c State Key Laboratory of Respiratory Diseases   (China)

^d INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^f UNIVERSITY OF BERGEN   (Norway)

^g China Office   (China)

Author keywords

China; Diabetes mellitus; Treatment outcome; Tuberculosis

Indexed keywords

ETHAMBUTOL; GLUCOSE; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

DIABETES; DISEASE CONTROL; DISEASE TREATMENT; HEALTH CARE; TUBERCULOSIS;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CHINA; CLINICAL FEATURE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DIABETES CONTROL; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RETROSPECTIVE STUDY; SPUTUM SMEAR; TREATMENT OUTCOME;

CHINA; GUANGDONG; GUANGZHOU;

CHINA; DIABETES MELLITUS; TREATMENT OUTCOME; TUBERCULOSIS;

ADOLESCENT; ADULT; AGE FACTORS; ANTITUBERCULAR AGENTS; BLOOD GLUCOSE; CHINA; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; HUMANS; INCIDENCE; LOST TO FOLLOW-UP; MALE; MASS SCREENING; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; SEX FACTORS; SPUTUM; TREATMENT FAILURE; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84886294520     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/tmi.12198     Document Type: Article

References (29)

1. Alisjahbana B, Sahiratmadja E, Nelwan EJ et al. (2007) The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clinical Infectious Diseases 45, 428-435.
2. Baker MA, Harries AD, Jeon CY et al. (2011) The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Medicine 9, 81.
3. Becerra MC, Freeman J, Bayona J et al. (2000) Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis. The International Journal of Tuberculosis and Lung Disease 4, 108-114.
4. Danaei G, Finucane MM, Lu Y et al. (2011) National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 378, 31-40.
5. Dominguez-Castellano A, Muniain MA, Rodriguez-Bano J et al. (2003) Factors associated with time to sputum smear conversion in active pulmonary tuberculosis. The International Journal of Tuberculosis and Lung Disease 7, 432-438.
6. Dooley KE & Chaisson RE (2009) Tuberculosis and diabetes mellitus: convergence of two epidemics. The Lancet Infectious Diseases 9, 737-746.
7. Dooley KE, Tang T, Golub JE, Dorman SE & Cronin W (2009) Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis. The American Journal of Tropical Medicine and Hygiene 80, 634-639.
8. International Diabetes Federation (2011) IDF Diabetes Atlas, 5th edn. International Diabetes Federation, Brussels. Available at: http://www.idf.org/diabetesatlas/ (accessed 2 June 2013).
9. Jeon CY & Murray MB (2008) Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Medicine 5, e152.
10. Jiménez-Corona ME, Cruz-Hervert LP, García-García L et al. (2013) Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes. Thorax 68, 214-220.
11. Kuaban C, Bame R, Mouangue L, Djella S & Yomgni C (2009) Non conversion of sputum smears in new smear positive pulmonary tuberculosis in Yaounde, Cameroon. East African Medical Journal 86, 219-225.
12. Li L, Lin Y, Mi F et al. (2012) Screening patients with tuberculosis for diabetes mellitus in China. Tropical Medicine and International Health 17, 1294-1301.
13. Lin Y, Li L, Mi F et al. (2012) Screening patients with diabetes mellitus for tuberculosis in China. Tropical Medicine and International Health 17, 1302-1308.
14. Maalej S, Belhaoui N, Bourguiba M et al. (2009) Pulmonary tuberculosis and diabetes. Retrospective study of 60 patients in Tunisia. La Presse Medicale 38, 20-24.
15. Mboussa J, Monabeka H, Kombo M, Yokolo D, Yoka-Mbio A & Yala F (2003) Course of pulmonary tuberculosis in diabetics. Revue de Pneumologie Clinique 59, 39-44.
16. Ministry of Health and Chinese Centre on TB Control and Prevention (CDC) (2008) National Tuberculosis Control Programme Guidelines. Peking Union Medical College Publishing House, Beijing, China.
17. Oxlade O, Schwartzman K, Pai M et al. (2010) Predicting outcomes and drug resistance in standardised treatment of active tuberculosis. European Respiratory Journal 26, 870-877.
18. Ruslami R, Aarnoutse RE, Alisjahbana B, van der Ven AJAM & van Crevel R (2010) Implications of the global increase of diabetes for tuberculosis control and patient care. Tropical Medicine and International Health 15, 1289-1299.
19. Singla R, Osman MM, Khan N, Al-Sharif N, Al-Sayegh MO & Shaikh MA (2003) Factors predicting persistent sputum smear positivity among pulmonary tuberculosis patients 2 months after treatment. The International Journal of Tuberculosis and Lung Disease 7, 58-64.
20. Singla R, Khan N, Al Sharif N et al. (2006) Influence of diabetes on manifestations and treatment outcome of pulmonary TB patients. The International Journal of Tuberculosis and Lung Disease 10, 74-79.
21. Stevenson CR, Critchley JA, Forouhi NG et al. (2007) Diabetes and the risk of tuberculosis: a neglected threat to public health. Chronic Illness 3, 228-245.
22. Telzak EE, Fazal BA, Pollard CL, Turett GS, Justman JE & Blum S (1997) Factors influencing time to sputum conversion among patients with smear-positive pulmonary tuberculosis. Clinical Infectious Diseases 25, 666-670.
23. Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC & Vandenbroucke JP (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Bulletin of the World Health Organization 85, 867-872.
24. Wada M (2000) The effectiveness of pyrazinamide-containing six-month short course chemotherapy. Kekkaku 75, 665-673.
25. Wang CS, Yang CJ, Chen HC et al. (2009) Impact of type 2 diabetes on manifestations and treatment outcome of pulmonary tuberculosis. Epidemiology and Infection 137, 203-210.
26. WHO (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia. Summary of Technical Report and Recommendations. World Health Organization, Geneva, Switzerland.
27. WHO (2011) WHO report. Global tuberculosis control 2011. World Health Organization, Geneva, Switzerland. WHO/HTM/TB/2011.16, 93.
28. Yang W, Lu J, Weng J et al. (2010) Prevalence of diabetes among men and women in China. New England Journal of Medicine 362, 1090-1101.
29. Zhang Q, Xiao H & Sugawara I (2009) Tuberculosis complicated by diabetes mellitus at Shanghai pulmonary hospital, China. Japanese Journal of Infectious Diseases 62, 390-391.